Programme Partners

PROGRAMME PARTNERS

Asia Primary Angioplasty Congress

The Asia Primary Angioplasty Congress (APAC), initiated by Tan TockSeng Hospital in Singapore, is the first dedicated meeting in Asia focused on primary angioplasty. Over the past 10 years, APAC has served as a collaborative platform for interventional cardiologists to exchange and stay updated on advancements in STEMI care. As part of its regional outreach, APAC has expanded beyond Singapore, partnering with cardiac societies around the region to step up local efforts to enhance the angioplasty landscape across Asia from Hong Kong, Taipei and most recently in Bali, Indonesia. In 2026, APAC will return to Singapore from 15-16 August. Continuing its hallmark interactive case-sharing format, APAC 2026 will feature concise lectures by key opinion leaders, focused sessions on various aspects of primary PCI and an exciting quiz competition for budding fellows.

Asian Pacific Society of Cardiology

The Asian Pacific Society of Cardiology (APSC) represents 24 cardiology societies in the Asia-Pacific region. The APSC hosts its main Congress every year. APSC 2026, will be held in Taipei, Taiwan on 14-17 May 2026 hosted by Taiwan Society of Cardiology at TICC. The Organizing Committee is chaired by Dr Jiunn-Lee Lin and Dr Yi-Heng Li and the APSC Central Congress Management Committee is chaired by Dr KW Park. APSC 2027 will be held in Yokohama, Japan on 26-28 March 2027 followed by APSC2028 in Bali, Indonesia and APSC2029 in Hong Kong. Scientific and education activities include APSC Young Community Initiatives, APSC Scholarships, Emerging Leadership Course Programs, Pilot Exit Exam, and Joint Symposia and webinars are held with other major international societies and with APSC Member Societies at their annual meetings. The official journal of APSC, JAPSC led by Editor-in-Chief, Dr. Khung Keong Yeo.

Bangladesh Society of Cardiovascular Intervention

Cardiological Society of India - National Interventional Council

Complex Cardiovascular Therapeutics

Complex Cardiovascular Therapeutics (CCT) is a global-scale annualmeeting started in 2001 for the up-to-date clinical therapies andinnovation, committed to provide all participants “true live demonstration” with “open exchanges of views and techniques” to the Complex PCI. To encourage active generational changes, we also striveto hand down safe and secure treatment of cardiovascular disease to thenext-generation doctors. For improved patient care across the globe, CCT shall keep on evolving as the center of advanced interventional andvascular medicine.

ENCORE SEOUL

ENCORE SEOUL is an annual conference jointly hosted by Samsung Medical Center, Yonsei University Severance Hospital and Seoul National University Hospital. It attracts over 3,000 participants annually, including the world's most renowned interventional cardiologists, interventional radiologists, vascular biologists and cardiovascular researchers from around the world. Live Demonstrations are the main focus of ENCORE SEOUL, featuring carefully selected cases to present updated treatment modalities, cutting-edge techniques, and insights into new devices and tools. In addition, it runs various didactic lectures with in-depth discussions in the fields of coronary, endovascular and structural heart diseases, providing a wide range of perspectives.

Endovascular Cardiac Complications

Please join and attend the ECC complications sessions at SingaporeLIVE 2027. 2 sessions will be held in the typical open-minded and interactive manner. Esteemed faculty members have been asked topresent their worst career complication.

European Association of Percutaneous Cardiovascular Interventions

The European Association of Percutaneous Cardiovascular Interventions (EAPCI) promotes excellence in interventional cardiology through education, research, advocacy, and professional development. As part of the European Society of Cardiology, it supports healthcare professionals in improving patient outcomes and advancing cardiovascular care worldwide.

Hong Kong Society of Transcatheter ENdo-cardiovascular Therapeutics (HKSTENT)

HKSTENT is the first and only formal Interventional Cardiology Society registered as a charitable organisation under the Inland Revenue Department of Hong Kong. It was founded with the aim of promoting education, research, andadvancement of Interventional Cardiology in Hong Kong and Asia for the benefit of interventionists, cardiologists, allied health workers, and the general public at large.

Indonesia Society Interventional Cardiology

Interventional Cardiovascular Society of Malaysia

Interventional Cardiovascular Society of Malaysia (ICSM) was formed under the umbrella of the National Heart Association of Malaysia (NHAM) in 2003. The society’s vision is to reduce the burden ofcardiovascular disease in Malaysia. ICSM mainly focus its work on the organisation of MYLIVE, an annualinternational cardiovascular “live” interventional conference. The MYLIVE meetings offer a unique opportunity for the cardiovascular fraternity and people in related fields to meet, discuss and network with colleagues from the region and abroad. ICSM has been invited to conduct educational sessions at many annualinternational cardiovascular meetings. Under the banner of the ICSM, a few cardiology centres have also shared their expertise in the transmissions of live interventional procedures to various conferences around the world.

Philippine Society of Cardiovascular Catheterization

The Philippine Society of Cardiovascular Catheterization andInterventions, Inc. (PSCCI) is the official component society of thePhilippine Heart Association composed of local and internationallytrained interventional cardiologists in the country. It was founded in1993 by a group of Filipino cardiologists who wish to promote theadvancement of diagnostic and therapeutic cardiac catheterization in thePhilippines. It aims to be the premiere medical society that sets the policies and defines the standards of excellence in delivering accessiblecardiovascular intervention locally and internationally. The society’smission is to adhere to the highest standards of cardiovascularintervention resulting to excellent patient care.

Sri Lanka College of Cardiology

Founded in 1969, the Sri Lanka Heart Associationis the apex professional body in Cardiac Care in Sri Lanka. It is a member of theWorld Heart Federation (WHF) and the Asian Pacific Society of Cardiology (APSC). It is also one of the founder members of the SAARCCardiac Society. With a history of more than 40 years; an active council comprising senior most Cardiologists in the country; and an equally active membership, today it has become the main gathering point for the Cardiologists of the country with the aim of further enhancing their professional knowledge while informing the public about cardiovascular health.

TCTAP

TCTAP offers the most comprehensive interventional cardiology program in the Asia-Pacific region featuring Coronary, Endovascular, and Structural Heart Disease. Over the past three decades, TCTAP has played an integral part in educating physicians and all affiliated medical professionals who specialize in and are interested in this field. Through close collaboration with global partner societies, TCTAP has emerged as a leading name in interventional therapy and is committed to continually enhancing the quality of medical care for heart patients.